Joana Cartocci, Co-founder & COO, Robeauté | Slush 2025
summary
Claims a soft micro-robot that propels via a tiny micropropeller, a steering unit and onboard tracking to move nonlinearly through brain tissue and carry interchangeable tool-extensions for diagnosis, monitoring and localized treatment. Device is in preclinical animal studies with validated movement and the company targets first in-human trials end of 2026. States over a billion people affected by brain disease and positions this as a platform for site- and patient-specific data.
AI-written summary · about